Shire, Impax Settle Litigation Related to Supply of Adderall XR Authorized Generic
February 08, 2013 at 08:04 AM EST
Shire plc (NASDAQ: SHPG ), announces that its subsidiary, Shire LLC, has settled all pending litigation with Impax Laboratories, Inc. (NASDAQ: IPXL ) over Shire's supply of an authorized generic version of Adderall XR. Shire has been supplying Impax with authorized generic Adderall XR since October 2009 pursuant to a supply agreement